BIOMAT Database Logo BIOMAT Database Logo

Interaction between plasma phenytoin and phenobarbital concentrations in epileptic patients. 1979

K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda

UI MeSH Term Description Entries
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
Saliva phenobarbital and phenytoin concentrations in epileptic adolescents.
April 1981, The Journal of pediatrics,
K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
Plasma levels of phenobarbital and phenytoin in epileptic outpatients.
January 1977, European neurology,
K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
Phenytoin-phenobarbital interaction: importance of free plasma phenytoin monitoring.
July 1988, Pharmacological research communications,
K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
Mephobarbital and phenobarbital plasma concentrations in epileptic patients treated with mephobarbital.
January 1979, Therapeutic drug monitoring,
K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.
July 1971, Annals of the New York Academy of Sciences,
K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay.
December 1975, Clinical pharmacology and therapeutics,
K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
Phenytoin and IgA concentrations in plasma and saliva in epileptic children.
January 1981, Acta paediatrica Scandinavica,
K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
Relationship between ischemic damage and concentrations of phenytoin and phenobarbital in the brain cortex of epileptic patients in vegetative state at death.
November 1996, Epilepsy research,
K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
A study of the interaction between omeprazole and phenytoin in epileptic patients.
July 1990, Therapeutic drug monitoring,
K Nishihara, and Y Kohda, and Y Saitoh, and Y Honda
Phenytoin and phenobarbital concentrations in renal insufficiency.
October 1984, Annals of internal medicine,
Copied contents to your clipboard!